Inhibition of EZH2 by ZLD1039 or miR-26a no longer induces tumour invading factors such as metalloprotease 2 and 9 (MMP2/9) and those related to epithelial-mesenchymal-transition (EMT) and, in contrast, induces differentiating factors. This evidence concerns the gene MMP2 and neoplasm.